Kestra Medical Technologies aims to raise $150M in IPO
Kirkland, Wash.-based Kestra Medical Technologies is aiming to raise about $150 million in its initial public offering, pricing shares between $14 and $16 on the Nasdaq, according to a new regulatory filing.
Kirkland, Wash.-based Kestra Medical Technologies is aiming to raise about $150 million in its initial public offering, pricing shares between $14 and $16 on the Nasdaq, according to a new regulatory filing.
- The maker of cardiac monitoring and therapeutic devices launched in 2014 and filed for an IPO earlier this month. It raised a $196 million round in 2024.
- The company, backed by Bain Capital, generated revenue of $27.5 million in the six-month period ended Oct. 31, up from $9.5 million in the year-ago period. It expanded headcount from 66 people in October 2020 to more than 300 employees today.
- Three of the four largest IPOs this year in the U.S. traded below their offer price in their first session, Bloomberg noted.
